Log in

Relevant bibliographies by topics / Clinical Outcomes

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Clinical Outcomes'

Author: Grafiati

Published: 4 June 2021

Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clinical Outcomes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clinical Outcomes"

1

Horikawa, Y., N. Tsuchiya, K. Yuasa, S. Narita, M. Saito, K. Takayama, T. Nara, et al. "CLINICAL OUTCOMES." Japanese Journal of Clinical Oncology 41, no. 3 (March 1, 2011): i6—i17. http://dx.doi.org/10.1093/jjco/hyq254.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Tanash, M., P. A. Gonchar, L. Ababneh, and H. Mohidat. "Clinical and Refractive Outcomes after Penetrating Keratoplasty (PKP)." Modern technologies in ophtalmology, no. 5 (August 20, 2018): 312–14. http://dx.doi.org/10.25276/2312-4911-2018-5-312-314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lavee, J., R. A. Beaupre, and A. J. Morgan. "Left ventricular assist devices (LVADs): clinical applications and outcomes." Clinical and Experimental Surgery. Petrovsky journal 8, no. 3 (2020): 123–28. http://dx.doi.org/10.33029/2308-1198-2020-8-3-123-128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Jeffrey, Adam Almaguer, and John Dennis Busowski. "Comparing Clinical Outcomes." Obstetrics & Gynecology 125 (May 2015): 75S. http://dx.doi.org/10.1097/01.aog.0000463157.35699.e2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Edwards, P., J. Riley, J. Brown, S. George, R. Fillingim, L. Waxenberg, J. Atchison, V. Wittmer, and M. Robinson. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S111. http://dx.doi.org/10.1016/j.jpain.2004.02.412.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Williams, D., P. Biswas, J. Kalbfleisch, R. Gracely, S. Chriscinske, and D. Clauw. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S111. http://dx.doi.org/10.1016/j.jpain.2004.02.413.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Palos, G., T. Mendoza, G. Mobley, S. Cantor, and C. Cleeland. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S111. http://dx.doi.org/10.1016/j.jpain.2004.02.414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Butler, S., S. Budman, K. Fernandez, C. Benoit, and R. Jamison. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S111. http://dx.doi.org/10.1016/j.jpain.2004.02.415.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gore, M., N. Brandenburg, E. Dukes, D. Hoffman, A. Snyder-Chavis, and K. Tai. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S112. http://dx.doi.org/10.1016/j.jpain.2004.02.416.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fernando, S., M. Ryan, L. Gordon, A. Gordon, and R. Kern. "Clinical outcomes measurement." Journal of Pain 5, no. 3 (April 2004): S112. http://dx.doi.org/10.1016/j.jpain.2004.02.417.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Clinical Outcomes"

1

Briggs, Timothy William Roy. "Clinical outcomes of autologous implantation." Thesis, University College London (University of London), 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.505121.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Taylor, Michael Dennis. "Prostate cancer clinical practice guidelines clinical and economic outcomes /." [Gainesville, Fla.] : University of Florida, 2005. http://purl.fcla.edu/fcla/etd/UFE0010098.

Full text

Abstract:

Thesis (Ph.D.)--University of Florida, 2005.
Typescript. Title from title page of source document. Document formatted into pages; contains 99 pages. Includes Vita. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

3

Wilson, Katherine Ann. "Does safety culture predict clinical outcomes?" Doctoral diss., University of Central Florida, 2007. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/2919.

Full text

Abstract:

Patient safety in healthcare has become a national objective. Healthcare organizations are striving to improve patient safety and have turned to high reliability organizations as those in which to model. One initiative taken on by healthcare is improving patient safety culture--shifting from one of a 'no harm, no foul' to a culture of learning that encourages the reporting of errors, even those in which patient harm does not occur. Lacking from the literature, however, is an understanding of how safety culture impacts outcomes. While there has been some research done in this area, and safety culture is argued to have an impact, the findings are not very diagnostic. In other words, safety culture has been studied such that an overall safety culture rating is provided and it is shown that a positive safety culture improves outcomes. However, this method does little to tell an organization what aspects of safety culture impact outcomes. Therefore, this dissertation sought to answer that question but analyzing safety culture from multiple dimensions. The results found as a part of this effort support previous work in other domains suggesting that hospital management and supervisor support does lead to improved perceptions of safety. The link between this support and outcomes, such as incidents and incident reporting, is more difficult to determine. The data suggests that employees are willing to report errors when they occur, but the low occurrence of such reportable events in healthcare precludes them from doing so. When a closer look was taken at the type of incidents that were reported, a positive relationship was found between support for patient safety and medication incidents. These results initially seem counterintuitive. To suggest a positive relationship between safety culture and medication incidents on the surface detracts from the research in other domains suggesting the opposite. It could be the case that an increase in incidents leads an organization to implement additional patient safety efforts, and therefore employees perceive a more positive safety culture. Clearly more research is needed in this area. Suggestions for future research and practical implications of this study are provided.
Ph.D.
Department of Psychology
Sciences
Psychology PhD

APA, Harvard, Vancouver, ISO, and other styles

4

Sharp, Charles Michael Francis. "Clinical outcomes in diffuse parenchymal lung disease." Thesis, University of Bristol, 2017. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.723507.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yee, Leland Jonathan. "Determinants of hepatitis C virus clinical outcomes." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2003. http://researchonline.lshtm.ac.uk/1620410/.

Full text

Abstract:

Hepatitis C virus (HCV) infection is characterized by a broad spectrum of clinical outcomes. An estimated 14%-46% of individuals exposed to HCV are able to clear the virus, while the other portion develops chronic (persistent) infections. Among the individuals with chronic HCV who are treated with interferon-based therapies, only a portion are able to experience sustained virological suppression. Similarly, a number of chronically infected individuals have autoimmune extrahepatic manifestations such as the presence of autoantibodies. The pathological mechanisms behind these phenomena are not known, but it is believed that host genetic factors may play a role. This thesis examines the hypothesis that host genetic factors may contribute to the diverse spectrum of HCV clinical outcomes. In addition, it examines the pathogenesis of antinuclear antibodies (ANA) in chronic HCV, and the effect of ANA positivity on the natural history of HCV. Correlations were observed between female gender and geographic location and ANA positivity. No relationships were observed for an effect of ANA positivity on response rates to interferon therapy. We observed a trend of ANA positivity with faster progression of HCV-related fibrosis, although this failed to achieve statistical significance. ANA-positive individuals tended to have more plasma cells in their liver than ANA-negative individuals. This study also observed a number of correlations between genotypes of the interferon induced genes encoding the myxovirus resistance 1 protein (MxA), 2'-5'oligo-adenylate synthase 1 (OAS-1), and protein kinase (PKR), as well as genes encoding cytotoxic T-lymphocyte antigen-4 (CTLA4), and inducible nitric oxide synthase (iNOS) (encoded by the NOS2A gene) with several outcomes including self-limiting versus chronic HCV infection, along with the response to interferon therapy. This study identified several factors to be correlated with ANA positivity in HCV. These factors may serve as future points for investigation by basic scientists understanding the mechanisms of HCV-mediated autoimmunity. Importantly, this study suggests that low titre ANA positivity should not be a contraindication to therapy. This study also highlighted the importance of several genetic pathways in HCV infection. These may serve as targets for future pharmacologic interventions or genetic tests designed to screen for those who will not benefit from interferon therapies.

APA, Harvard, Vancouver, ISO, and other styles

6

Ritchie, Robert Wilson. "Improving clinical outcomes in renal HIFU therapy." Thesis, University of Oxford, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.572839.

Full text

Abstract:

The rising incidence of small, asymptomatic renal tumours discovered usmg abdominal imaging during the investigation of unrelated symptoms has fuelled the desire for new therapies which avoid surgical excision. Extracorporeal High Intensity Focused Ultrasound (HIFU) was proposed as one of these modalities but so far clinical research has been ,~." inconclusive. The present work was designed to improve these clii teal outcomes through the conduct of further clinical trials, laboratory based research and the translation of new technology into existing HIFU devices. A Phase II clinical trial of patients (n=13) with newly diagnosed <4cm renal tumours (clinical stage T1a) was designed, peer reviewed and received ethical approval (Ox REC 09/H0606104). Ten of 13 patients underwent renal HIFU using a clinical HIFU device (Model JCIJC200, HAIFU, China). One patient could not be treated due to poor tumour visualisation after anaesthesia and two patients could not be treated as they became unwell before or during anaesthesia. Histological evidence of HIFU ablation in either tumour or normal renal parenchyma was seen in all ten patients. Evidence of sub-total tumour ablation was seen in 8/10 of patients. Grade 1 «50%), 2 (50-90%) & 3 (90-99%) ablation was achieved in 4/10, 3/1 0 & 3/1 0 patients respectively but complete (100%) tumour ablation was not possible. HIFU treatment caused minimal morbidity - no Grade III- V (Clavien-Dindo) complications related to HIFU treatment occurred. Grade I skin pain and induration was seen in 9/1 0 patients; Grade II skin pain occurred in a single patient. Patient demographics, imaging and tumour characteristics were used to design parameters to improve patient selection for renal HIFU. The tumour location, thickness of peri-nephric fat and renal nephrometry score were useful predictors of successful screening for treatment. Page /ii Dr R. W Ritchie Nutiield Department of Surgical Sciences - TT 2012 Abstract Diligent use of these factors could limit unnecessary treatments and Improve ablation outcomes. , It is well known that ultrasound imaging of small renal masses can be challenging. Ultrasound imaging often deteriorates further during HIFU as the abdominal wall and fat tissues swell and cause increased attenuation. This loss of imaging quality was clearly demonstrated in this clinical trial and resulted in the early termination of treatment, before ,#,J' ... ~ .•.. endpoints were reached, in a number of cases. The current clinical method for monitoring the success of HIFU ablation using hyperecho analysis of B-mode ultrasound images is also questionable. Laboratory based studies using ex-vivo bovine liver subjected to HIFU confirmed that hyperecho monitoring had low sensitivity, predictive values and overall accuracy. A novel method of HIFU monitoring - passive mapping of the emissions received from acoustic cavitation activity and other sources of non-linearity during HIFU treatment - is believed to represent a significant opportunity to improve feedback. This technique uses the passively received signature of cavity activity which, when time-reversed, gives high- resolution images of the precise location of the activity. Laboratory-based ex-vivo work, using a commercially available ultrasound system (z.one, Zonare, USA), demonstrates its superiority over hyperecho monitoring. Indeed, thresholds could be applied to successfully predict HIFU ablation with high sensitivity and specificity. This technique was successfully translated into the clinical setting through the design of a Passive Acoustic Mapping (P AM) device. Custom-built receiving elements were applied without limiting the function of the existing HIFU devices. Both pre-clinical and ethically- Page [iii Dr R. W Ritchie Nuffield Department of Surgical Sciences - TT 2012 Abstract approved clinical studies demonstrated its safe integration without significant impact on the device energy output or treatment accuracy. Using similar passive beamfonning algorithms, acoustic cavitation activity was successfully mapped and corresponded with the location of thermal ablation in both ex-vivo tissue phantoms and during clinical HIFU therapy. ,~-' It is believed that the development of new patient selection paral~~tel's will elimil?ate target those patients who are most suitable for renal HIFU - small tumours, minimal peri-nephric fat & low nephrometry score .. The use of P AM will lead to a significant improvement in the efficacy of treatment. It can be successfully applied to existing devices and predicts the location and extent ofHIFU ablation with greater accuracy that existing techniques.

APA, Harvard, Vancouver, ISO, and other styles

7

Akhatova, Elena. "Do clinical pharmacy servicesimprove outcomes for patientswith heart failure (HF)? : Do clinical pharmacy servicesimprove outcomes for patientswith heart failure (HF)?" Thesis, Umeå universitet, Kemiska institutionen, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-106301.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Fedt, Lauren Alexandra, and Lauren Alexandra Fedt. "Teleaudiology: Clinical Outcomes from Adults with Hearing Loss." Diss., The University of Arizona, 2017. http://hdl.handle.net/10150/625383.

Full text

Abstract:

Outside of major metropolitan areas, Arizona has limited options for hearing healthcare. The Arizona Affordable Hearing Aid Task Force proposed the development of a statewide program to provide low-cost hearing aids and audiologic care to low-income residents. The purpose of this review was to determine the status of the literature on the clinical outcomes of teleaudiology services for evaluations and hearing aid fittings which could be used to serve inhabitants of rural counties and address the goals of the Task Force. A literature search was performed to identify articles with original research in teleaudiology in the areas of evaluation and treatment and yielded 234 results. After exclusion criteria were applied, there were 15 articles for review; 10 articles focused on audiological evaluation and 5 articles focused on verification, validation, and counseling for hearing aid fittings. Evaluation-related articles showed that pure-tone air conduction testing was generally within the ± 5 dB acceptable range of variability, with little evidence on bone conduction or speech testing reliability. Studies reporting real-ear measurements with probe microphones were shown to yield similar results in traditional and teleaudiology fitting sessions and validation measures documented similar or better outcomes from teleaudiology fittings. Based on the literature, it is concluded that the use of teleaudiology is feasible for hearing aid fittings and counseling in rural areas, if associated barriers related to costs and limitations related to the availability of technology are overcome.

APA, Harvard, Vancouver, ISO, and other styles

9

Mazlan-Kepli, Wardati. "Antiplatelet therapy and clinical outcomes in cardiovascular diseases." Thesis, University of Glasgow, 2016. http://theses.gla.ac.uk/7831/.

Full text

Abstract:

Cardiovascular diseases (CVD) is a leading cause of death in the world. Despite effective treatment regimens for ischaemic heart disease (IHD) and ischaemic stroke, mortality and recurrence rates remain high. Antiplatelet therapy is on effective treatment and reduces the risk of recurrent heart attack and stroke. Nevertheless, there are patients who stopped or interrupted their antiplatelet therapy for certain reasons or some patients may be resistant or poor responders to antiplatelet therapy. Furthermore, there is evidence of rebound effect in platelet activity after antiplatelet cessation and this may associate with increased risk of cardiovascular event. This thesis is divided into five main chapters (chapters 3 to 7) which attempt to provide data to help resolve the uncertainty. Chapter 1 highlights the background of cardiovascular diseases and the global burden of cardiovascular and cerebrovascular diseases. The metabolism of platelets, antiplatelet therapy and current antiplatelet therapy guidelines are described, followed by discussion of the risk of cardiovascular event and changes in antiplatelet therapy. Chapter 2 describes the data source from Virtual International Stroke Trial Archive (VISTA) and National Health Service Greater Glasgow and Clyde (NHSGGC) Safe Haven, followed by definition of outcome measures. In chapter 3, Virtual International Stroke Trial Archive (VISTA) data was examined to test whether continue with the same antiplatelet therapy or changing to a new antiplatelet regimen reduces the risk of subsequent events in patients who experience a stroke whilst taking antiplatelet therapy. The findings indicate that subjects who switch to a new antiplatelet regimen after stroke did not have a lower early recurrence rate than subjects who continued with the same antiplatelet therapy. Observations on bleeding complications were similar in both groups. However, changing antiplatelet regimen after stroke was associated with more favourable functional outcome across a full scale modified Rankin Scale (mRS) at 90 days. In chapter 4, association between early or later initiation of antiplatelet with a recurrent ischaemic stroke and bleeding complications was assessed using VISTA data. The findings indicate that there was no association between a recurrent ischaemic stroke and timing of initiation of antiplatelet drug after stroke. However, early initiation was associated with increased risk of bleeding. In terms of functional outcomes, this study demonstrated that the mid-time and late initiation of antiplatelet therapy after acute stroke are associated with better functional outcomes compared with early initiation. In chapter 5, a nested case-control study was performed to explore the rate of antiplatelet cessation and interruption in a sample of patients with recent ischaemic stroke and to assess the risk of cardiovascular events associated with cessation and interruption of antiplatelet. It was found that there was no increased risk of cardiovascular event among patients who had early cessation or interrupted/stopped antiplatelet therapy within 90 days following acute ischaemic stroke. In chapter 6, the incidence and predictors of cardiovascular events after DAPT cessation were evaluated. The incidence of cardiovascular event while taking DAPT and following discontinuation of DAPT was 15.7% and 16.7% respectively. This study found that increasing age was associated with an increased risk of cardiovascular event, whereas, revascularization-treated patients and longer duration of DAPT, were each associated with a decreased risk. The duration of DAPT six months and less was associated a significantly higher risk for cardiovascular event. In chapter 7, an untargeted metabolomics analysis was performed while on DAPT (aspirin plus ticagrelor) and once they stopped ticagrelor to identify metabolite changes associated with cardiovascular events after stopping DAPT. Ten ACS patients were recruited in this study and data were analysed for seven patients. Three hundred eleven putative metabolites were identified. This study found 16 putative metabolites significantly altered following ticagrelor cessation. Of these, seven metabolites were from lipid pathway and down-regulated some up to 3-fold. On the other hand, adenosine, from nucleotide metabolism was upregulated up to 2.6-fold. It concluded that there are changes in numerous pathways following DAPT discontinuation and whether these changes differ in patients who have cardiovascular event after stopping DAPT warrant further investigation. In chapter 8, a summary of the findings of this thesis are presented as well as the future directions of research in this area.

APA, Harvard, Vancouver, ISO, and other styles

10

Okasheh, Rasha Othman Ahmad. "Clinical measurement of functional outcomes of pulmonary rehabilitation." Thesis, Sheffield Hallam University, 2011. http://shura.shu.ac.uk/20771/.

Full text

Abstract:

Chronic Obstructive Pulmonary Disease "COPD" is a chronic condition characterised by progressive deterioration in the lung function. COPD co exists with other clinical conditions resulting into complex cases. People with COPD suffer from progressive functional limitations and participation restrictions. Pulmonary Rehabilitation "PR" is a multidisciplinary intervention designed to improve functional outcomes in people with COPD. Despite the established effectiveness of PR, a number of clinical problems in the provision of PR services remain unresolved. In order to address these problems an outcome measure that is appropriate for implementation in clinical settings is required. The aim of this thesis was to develop a clinical tool for the measurement of functional outcomes of PR in people with COPD. The research process included three phases. A "conceptualisation" phase, the phase of "development", and a "clinical testing" phase. During the phase of conceptualisation a critical review of the literature was performed. This resulted in the development of a framework for the measurement of functioning in people with COPD, and the identification of the specifications for a clinical outcome measure. The phase of development resulted in the selection of the TELER method of measurement and the development and validation of TELER "function" indicators using extensive qualitative research that used indepth interviews and focus groups methods. The final phase was testing the indicators in clinical PR settings. This resulted in providing evidence of the usefulness of the TELER "function" indicators in producing informative data appropriate for full clinimetric analysis. The clinimetric analysis of TELER data developed new insights about the provision of PR. This thesis has contributed to the development in the measurement of the functional outcomes of PR, by providing a new clinical tool that is underpinned by sound theoretical, clinical and empirical knowledge. The tool is appropriate for use in clinical evaluation, and has the potential to resolve clinical problems in the provision of PR.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Clinical Outcomes"

1

Focus Meeting on Clinical Outcomes (1994?). Clinical outcomes: Spine focus issue. Hagerstown, MD: J.B. Lippincott, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Outcomes management: Applications to clinical practice. St. Louis, Mo: Mosby, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Patrice, Spath, ed. Clinical paths: Tools for outcomes management. Chicago: American Hospital Pub., 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Michael, Berger. Outcomes and effectiveness in clinical psychology practice. Leicester: The British Psychological Society, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Chiappelli, Francesco, ed. Evidence-Based Practice: Toward Optimizing Clinical Outcomes. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-05025-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

service), SpringerLink (Online, ed. Evidence-Based Practice: Toward Optimizing Clinical Outcomes. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Black, Joyce M. Medical-surgical nursing: Clinical management for positive outcomes. 8th ed. St. Louis, Mo: Saunders/Elsevier, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lenderking, William R., and Dennis A. Revicki. Advancing health outcomes research methods and clinical applications. McLean, VA: Degnon Associates, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Black, Joyce M. Medical-surgical nursing: Clinical management for positive outcomes. 7th ed. St.Louis,MS: Elsevier Saunders, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

M, Black Joyce, Hawks Jane Hokanson, and Keene Annabelle M, eds. Medical-surgical nursing: Clinical management for positive outcomes. 6th ed. Philadelphia: W.B. Saunders, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Clinical Outcomes"

1

de Souza, Raphael F. "Clinical Outcomes." In Mandibular Implant Prostheses, 263–71. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-71181-2_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Boldt, Jens G., Jeannette Petrich-Munzinger, Peter A. Keblish, Mario Bizzini, Urs K. Munzinger, N. W. Thompson, A. L. Ruiz, et al. "Clinical Outcomes." In Primary Knee Arthroplasty, 99–138. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18816-9_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Micheletto, Claudio. "Clinical Outcomes." In Long-Term Oxygen Therapy, 195–210. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2580-6_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hettrich, Carolyn M., and Kurt P. Spindler. "ACL Clinical Outcomes." In The ACL Handbook, 29–40. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-0760-7_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gardner, John. "Measuring Clinical Outcomes." In Rethinking the Clinical Gaze, 169–92. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-53270-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Powell, Lynda H., Peter G. Kaufmann, and Kenneth E. Freedland. "Outcomes." In Behavioral Clinical Trials for Chronic Diseases, 209–36. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-39330-4_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lo, Benjamin W. Y., Filip Stojic, Julian Spears, Tom A. Schweizer, and R. Loch Macdonald. "Clinical Outcomes, Stroke Trials, and Cognitive Outcome." In The Behavioral Consequences of Stroke, 283–314. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7672-6_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Leach, Justin M., Inmaculada Aban, and Gary R. Cutter. "Outcomes in Clinical Trials." In Principles and Practice of Clinical Trials, 891–914. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-319-52636-2_70.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Leach, Justin M., Inmaculada Aban, and Gary R. Cutter. "Outcomes in Clinical Trials." In Principles and Practice of Clinical Trials, 1–25. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-52677-5_70-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

De Sousa, Avinash, Reetika Dikshit, Pragya Lodha, Akansha Rathi Maheshwari, and Amresh Shrivastava. "Stigma: A Clinical Risk Factor for Psychopathology and Recovery." In Schizophrenia Treatment Outcomes, 145–55. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-19847-3_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Clinical Outcomes"

1

Goodell, Teresa T., Steven L. Jacques, and Kenton W. Gregory. "Evaluating clinical outcomes of PDT." In BiOS 2001 The International Symposium on Biomedical Optics, edited by Thomas J. Dougherty. SPIE, 2001. http://dx.doi.org/10.1117/12.424432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Grant, Rebecca, William Brindle, Edward Rycroft, Oluwadara Oyewole, Sarah Morgan, Caitlyn Taylor, Norma McAvoy, et al. "P104 Clinical outcomes in severe oesophagitis." In Abstracts of the BSG Annual Meeting, 20–23 June 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-bsg.161.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sbrollini, Agnese, Sofia Romagnoli, Ilaria Marcantoni, Luca Burattini, Micaela Morettini, and Laura Burattini. "Neonatal Clinical Outcomes: a Comparative Analysis." In 2022 IEEE International Symposium on Medical Measurements and Applications (MeMeA). IEEE, 2022. http://dx.doi.org/10.1109/memea54994.2022.9856584.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Davis, A. E., D. B. Johnson, and J. A. Bastarache. "Clinical Outcomes in Immunotherapy Induced Pneumonitis." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mitchell, O. J. L., R. Kohn, S. Neefe, L. Meadows, M. Lynch, W. D. Schweickert, B. S. Abella, and M. G. S. Shashaty. "Clinical Features and Outcomes of Non-Hospitalized Patients Experiencing Clinical Emergencies." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2870.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Walsh, Michael, John Barton, Brendan O'Flynn, Cian O'Mathuna, Anne Hickey, and John Kellett. "On the relationship between cummulative movement, clinical scores and clinical outcomes." In 2012 IEEE Sensors. IEEE, 2012. http://dx.doi.org/10.1109/icsens.2012.6411587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Amado Diago, Carlos Antonio, Beatriz Abascal Bolado, Juan Agüero Calvo, Begoña Durantes, Milagros Ruiz De Infante, Armando Raúl Guerra, María Teresa García-Unzueta, Bernardo Alio Lavín, and Elena Arnaiz-García. "Sarcopenia index correlates with COPD clinical outcomes." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa722.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bihari, S., A. D. Bersten, E. Paul, D. L. Dixon, P. Sinha, C. S. Calfee, A. D. Nichol, C. L. Hodgson, and The PHARLAP Study Investigators. "Ards Phenotypes with Distinct Clinical Outcomes Identified in PHARLAP Clinical Trial Cohort." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gray, P., A. Molnar, and B. Firman. "Early High-Dose Caffeine Citrate: Neonatal and Neurodevelopmental Outcomes." In 7th International Conference on Clinical Neonatology—Selected Abstracts. Thieme Medical Publishers, 2018. http://dx.doi.org/10.1055/s-0038-1647088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tseng, C., W. Fang, K. Huang, P. Chang, Y. Chung, Y. Wang, IS Douglas, and M. Lin. "Clinical Outcomes in Patients with Ventilator Related Pancreatitis." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Clinical Outcomes"

1

Ciapponi, Agustín. Do rapid-response systems improve clinical outcomes? SUPPORT, 2017. http://dx.doi.org/10.30846/1701152.

Full text

Abstract:

Rapid-response systems were created to improve recognition of and response to deterioration of hospitalized patients, with the goal of reducing the incidence of cardiorespiratory arrest and hospital mortality. A rapid-response system consists of providers who immediately assess and treat unstable patients. Examples include medical emergency teams and rapid response teams. Preliminary evidence of improvements in patient outcomes led to widespread utilization of rapid response systems.

APA, Harvard, Vancouver, ISO, and other styles

2

Brewster, Abenaa, Susan Peterson, Scott Cantor, Robert Volk, Yu Shen, Isabelle Bedrosian, Herbert Dupont, and Patricia Parker. Contralateral Prophylactic Mastectomy and Breast Cancer: Clinical and Psychosocial Outcomes. Patient-Centered Outcomes Research Institute (PCORI), October 2018. http://dx.doi.org/10.25302/10.2018.ce.13046293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Du, Xianglin. Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada395149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Du, Xianglin. Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery. Fort Belvoir, VA: Defense Technical Information Center, June 2000. http://dx.doi.org/10.21236/ada382511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rada, Gabriel. How do clinical pathways affect patient outcomes, professional practice and hospital costs? SUPPORT, 2016. http://dx.doi.org/10.30846/1608105.

Full text

Abstract:

Clinical pathways are structured multidisciplinary care plans used by healthcare providers to detail essential steps in the care of patients with a specific clinical problem. The use of clinal pathways is intended to link evidence to practice and to optimise clinical outcomes whilst maximising clinical efficiency.

APA, Harvard, Vancouver, ISO, and other styles

6

Jayasinghe, Ravindri, Sonali Ranasinghe, Chandrani Kuruppu, Umesh Jayarajah, and Sanjeewa Seneviratne. Clinical characteristics and outcomes of acute pancreatitis following spinal surgery: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0017.

Full text

Abstract:

Review question / Objective: This study reviews the current evidence on clinical characteristics and outcome of Acute Pancreatitis following spinal surgery. Condition being studied: Acute pancreatitis in spinal surgery. Information sources: All articles were searched electronically using PubMed/Medline, Scopus, EMBASE, Cochrane CENTRAL, and Latin American & Caribbean Health Sciences Literature (LILACS) before May 2020 without any restriction in the language or status of publication. Key words related to acute pancreatitis and its complications and various types of spinal surgeries were searched in the title and abstract fields.

APA, Harvard, Vancouver, ISO, and other styles

7

Liu, Hongliang, and Qianyun Pang. Lidocaine and oncologic outcomes—a systematic review from in vivo animal studies and clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0161.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

DiBenedetti, Dana B., T. Michelle Brown, Carla Romano, Claire Ervin, Sandy Lewis, and Sheri Fehnel. Conducting Patient Interviews Within a Clinical Trial Setting. RTI Press, August 2018. http://dx.doi.org/10.3768/rtipress.2018.op.0054.1808.

Full text

Abstract:

Qualitative data centered on patients’ experiences and perspectives typically go uncollected in clinical trial settings. Yet patients’ treatment experiences offer complementary insights and context on topics such as disease management, treatment gaps, and previous treatments outside of those gathered in traditional patient-reported outcome questionnaires. Qualitative interviews can capture patients’ perceptions of treatment needs, more fully explore meaningful changes experienced as a result of treatment, and reveal outcomes that are most important to patients. Asking patients detailed questions can provide insight into the “why” of a patient’s expressed thought or feeling. The inclusion of patient interviews within clinical trials is a relatively new and evolving field of research. This article delineates the types of data that may be collected during interviews with clinical trial participants and outlines two approaches to conducting qualitative research in the clinical trial setting, with a focus on maximizing the value of the resulting data.

APA, Harvard, Vancouver, ISO, and other styles

9

Leavy, Michelle B., Costas Boussios, Robert L. Phillips, Jr., Diana Clarke, Barry Sarvet, Aziz Boxwala, and Richard Gliklich. Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Final Report. Agency for Healthcare Research and Quality (AHRQ), June 2022. http://dx.doi.org/10.23970/ahrqepcwhitepaperdepressionfinal.

Full text

Abstract:

Objective. The objective of this project was to demonstrate the feasibility and value of collecting harmonized depression outcome measures in the patient registry and health system settings, displaying the outcome measures to clinicians to support individual patient care and population health management, and using the resulting measures data to support patient-centered outcomes research (PCOR). Methods. The harmonized depression outcome measures selected for this project were response, remission, recurrence, suicide ideation and behavior, adverse effects of treatment, and death from suicide. The measures were calculated in the PRIME Registry, sponsored by the American Board of Family Medicine, and PsychPRO, sponsored by the American Psychiatric Association, and displayed on the registry dashboards for the participating pilot sites. At the conclusion of the data collection period (March 2020-March 2021), registry data were analyzed to describe implementation of measurement-based care and outcomes in the primary care and behavioral health care settings. To calculate and display the measures in the health system setting, a Substitutable Medical Apps, Reusable Technology (SMART) on Fast Healthcare Interoperability Resource (FHIR) application was developed and deployed at Baystate Health. Finally a stakeholder panel was convened to develop a prioritized research agenda for PCOR in depression and to provide feedback on the development of a data use and governance toolkit. Results. Calculation of the harmonized outcome measures within the PRIME Registry and PsychPRO was feasible, but technical and operational barriers needed to be overcome to ensure that relevant data were available and that the measures were meaningful to clinicians. Analysis of the registry data demonstrated that the harmonized outcome measures can be used to support PCOR across care settings and data sources. In the health system setting, this project demonstrated that it is technically and operationally feasible to use an open-source app to calculate and display the outcome measures in the clinician’s workflow. Finally, this project produced tools and resources to support future implementations of harmonized measures and use of the resulting data for research, including a prioritized research agenda and data use and governance toolkit. Conclusion. Standardization of outcome measures across patient registries and routine clinical care is an important step toward creating robust, national-level data infrastructure that could serve as the foundation for learning health systems, quality improvement initiatives, and research. This project demonstrated that it is feasible to calculate the harmonized outcome measures for depression in two patient registries and a health system setting, display the results to clinicians to support individual patient management and population health, and use the outcome measures data to support research. This project also assessed the value and burden of capturing the measures in different care settings and created standards-based tools and other resources to support future implementations of harmonized outcome measures in depression and other clinical areas. The findings and lessons learned from this project should serve as a roadmap to guide future implementations of harmonized outcome measures in depression and other clinical areas.

APA, Harvard, Vancouver, ISO, and other styles

10

Uneke, Chigozie Jesse. What are the effects of printed educational materials on professional practice and healthcare outcomes? SUPPORT, 2016. http://dx.doi.org/10.30846/160812.

Full text

Abstract:

Printed educational materials (PEMs), including clinical guidelines, monographs and publications in peer-reviewed journals, are common channels to distribute recommendations for clinical care and evidence to inform the practice of healthcare providers. PEMs are used across a range of settings as a strategy to improve professional practice and healthcare outcomes through promoting clinical practices that have been shown to be beneficial and discouraging the use of ineffective interventions. The wide use of PEMs in many settings, particularly in the form of clinical guidelines, is linked to the fact that they are seen as familiar, accessible, relatively inexpensive and convenient.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!